In an in vitro model of human tuberculosis, monocyte-microglial networks regulate matrix metalloproteinase-1 and -3 gene expression and secretion via a p38 mitogen activated protein kinase-dependent pathway

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Green, Justin A ^a   Rand, Lucinda ^a   Moores, Rachel ^a   Dholakia, Shruti ^a   Pezas, Theodore ^a   Elkington, Paul T ^a,b   Friedland, Jon S ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Central nervous system; Immunopathology; Matrix metalloproteinase; Mitogen activated protein kinase; Tuberculosis

Indexed keywords

CASEIN; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STROMELYSIN;

ARTICLE; BACTERIUM IDENTIFICATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MATRIX METALLOPROTEINASE 1 GENE; MATRIX METALLOPROTEINASE 3 GENE; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NERVE CELL NETWORK; NONHUMAN; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUBERCULOSIS; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84883082836     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-107     Document Type: Article

References (27)

1. World Health Organization Global Tuberculosis Control 2010, Geneva, World Health Organization.
2. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F, Lipman M, Edwards DR, Robertson BD, DArmiento J, Friedland JS. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011, 121:1827-1833. 10.1172/JCI45666, 3083790, 21519144.
3. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001, 2:502-511. 10.1038/35081571, 11433375.
4. Parks WC, Mecham RP. Matrix metalloproteinases 1998, San Diego: Academic Press.
5. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573. 10.1016/j.cardiores.2005.12.002, 16405877.
6. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 2006, 203:1007-1019. 10.1084/jem.20051342, 2118280, 16585265.
7. Prinz M, Mildner A. Microglia in the CNS: immigrants from another world. Glia 2011, 59:177-187. 10.1002/glia.21104, 21125659.
8. Green JA, Dholakia S, Janczar K, Ong CW, Moores R, Fry J, Elkington PT, Roncaroli F, Friedland JS. Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFalpha, NFkappaB, p38 and caspase 8 dependent pathways. J Neuroinflammation 2011, 8:46. 10.1186/1742-2094-8-46, 3113956, 21569377.
9. Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, Moores RC, Bullen A, Porter JC, Agranoff D, Edwards DR, Friedland JS. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J Immunol 2010, 184:6492-6503. 10.4049/jimmunol.0903811, 20483790.
10. Nuttall RK, Silva C, Hader W, Bar-Or A, Patel KD, Edwards DR, Yong VW. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia 2007, 55:516-526. 10.1002/glia.20478, 17216595.
11. Green JA, Tran CT, Farrar JJ, Nguyen MT, Nguyen PH, Dinh SX, Ho ND, Ly CV, Tran HT, Friedland JS, Thwaites GE. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS One 2009, 4:e7277. 10.1371/journal.pone.0007277, 2748711, 19789647.
12. Harris JE, Nuttall RK, Elkington PT, Green JA, Horncastle DE, Graeber MB, Edwards DR, Friedland JS. Monocyte-astrocyte networks regulate matrix metalloproteinase gene expression and secretion in central nervous system tuberculosis in vitro and in vivo. J Immunol 2007, 178:1199-1207.
13. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004, 351:1741-1751. 10.1056/NEJMoa040573, 15496623.
14. Rand L, Green JA, Saraiva L, Friedland JS, Elkington PT. Matrix metalloproteinase-1 is regulated in tuberculosis by a paraminosalicylic acid-sensitive cascade. J Immunol 2009, 182:5865-5872. 10.4049/jimmunol.0801935, 19380835.
15. Elkington PT, Green JA, Emerson JE, Lopez-Pascua LD, Boyle JJ, OKane CM, Friedland JS. Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis. Am J Respir Cell Mol Biol 2007, 37:431-437. 10.1165/rcmb.2007-0011OC, 17575075.
16. Harris JE, Green JA, Elkington PT, Friedland JS. Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion. J Leukoc Biol 2006, 81:548-556.
17. Elkington PT, Emerson JE, Lopez-Pascua LD, OKane CM, Horncastle DE, Boyle JJ, Friedland JS. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 2005, 175:5333-5340.
18. Elkington PT, Green JA, Friedland JS. Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J Immunol Methods 2006, 309:115-119. 10.1016/j.jim.2005.11.010, 16386754.
19. Elkington PT, Nuttall RK, Boyle JJ, OKane CM, Horncastle DE, Edwards DR, Friedland JS. Mycobacterium tuberculosis but not vaccine BCG specifically up-regulates matrix metalloproteinase-1. Am J Respir Crit Care Med 2005, 172:1596-1604. 10.1164/rccm.200505-753OC, 16141443.
20. Tommasi S, Zheng A, Weninger A, Bates SE, Li XA, Wu X, Hollstein M, Besaratinia A. Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization. Nucleic Acids Res 2013, 41:182-195. 10.1093/nar/gks1051, 3592471, 23143272.
21. Lee HE, Berkowitz P, Jolly PS, Diaz LA, Chua MP, Rubenstein DS. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J Biol Chem 2009, 284:12524-12532. 10.1074/jbc.M808204200, 2673318, 19270308.
22. Yang CS, Shin DM, Lee HM, Son JW, Lee SJ, Akira S, Gougerot-Pocidalo MA, El-Benna J, Ichijo H, Jo EK. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell Microbiol 2008, 10:741-754. 10.1111/j.1462-5822.2007.01081.x, 18028450.
23. Kang YJ, Chen J, Otsuka M, Mols J, Ren S, Wang Y, Han J. Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J Immunol 2008, 180:5075-5082.
24. Strassburger M, Braun H, Reymann KG. Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Eur J Pharmacol 2008, 592:55-61. 10.1016/j.ejphar.2008.06.099, 18638472.
25. Kim JY, Kim WJ, Kim H, Suk K, Lee WH. The Stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis. Immune Netw 2009, 9:90-97. 10.4110/in.2009.9.3.90, 2803300, 20107538.
26. Park S, Jung HH, Park YH, Ahn JS, Im YH. ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression. Biochem Biophys Res Commun 2011, 407:680-686. 10.1016/j.bbrc.2011.03.075, 21440529.
27. Borghaei RC, Rawlings PL, Javadi M, Woloshin J. NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem Biophys Res Commun 2004, 316:182-188. 10.1016/j.bbrc.2004.02.030, 15003528.